Literature DB >> 2339678

Methylmalonic aciduria due to a new defect in adenosylcobalamin accumulation by cells.

B A Cooper1, D S Rosenblatt, D Watkins.   

Abstract

A child with methylmalonic aciduria due to failure to accumulate adocbl in mitochondria has a phenotype similar to cblA disease. Deficient utilization of labeled propionate by his fibroblasts is corrected by their fusion with those from cblA patients, indicating that he belongs to a different complementation class and probably is deficient in a different gene product. The defect appears not to be due to reduced affinity of enzymes for adocbl, or for ATP, and the minimal thiol required for adocbl synthesis is not different from that of extracts of normal cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2339678     DOI: 10.1002/ajh.2830340207

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  4 in total

1.  Identification of the gene responsible for the cblA complementation group of vitamin B12-responsive methylmalonic acidemia based on analysis of prokaryotic gene arrangements.

Authors:  C Melissa Dobson; Timothy Wai; Daniel Leclerc; Aaron Wilson; Xuchu Wu; Carole Doré; Thomas Hudson; David S Rosenblatt; Roy A Gravel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-15       Impact factor: 11.205

2.  Complementation studies in the cblA class of inborn error of cobalamin metabolism: evidence for interallelic complementation and for a new complementation class (cblH).

Authors:  D Watkins; N Matiaszuk; D S Rosenblatt
Journal:  J Med Genet       Date:  2000-07       Impact factor: 6.318

3.  Severe Neonatal Metabolic Decompensation in Methylmalonic Acidemia Caused by CblD Defect.

Authors:  R Parini; F Furlan; A Brambilla; D Codazzi; S Vedovati; C Corbetta; T Fedeli; B Merinero; B Pérez; M Ugarte
Journal:  JIMD Rep       Date:  2013-05-19

4.  Restricted role for methionine synthase reductase defined by subcellular localization.

Authors:  D S Froese; X Wu; J Zhang; R Dumas; W M Schoel; M Amrein; R A Gravel
Journal:  Mol Genet Metab       Date:  2008-01-24       Impact factor: 4.797

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.